A blood test can accurately predict whether someone without a known risk of preeclampsia is likely to develop the potentially ...

Shihabeddin et al utilized single-cell RNA-Seq analysis of adult P23H zebrafish animals to identify transcription factors (e2fs, Prdm1a, Sp1) expressed selectively in neural progenitors and immature ...

Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and Lonza, one of the world's largest contract development and manufacturing organizations ...

NG-350A is a next generation, systemically administered immunotherapy designed to drive intratumoral expression of a CD40 agonist monoclonal antibody in both ...

U.S. IND clearance follows recent approval of CTA for EPI-321 in facioscapulohumeral muscular dystrophy (FSHD) in New Zealand ...

ORNL scientists introduce a biosensor for real-time RNA monitoring in plants, promising advancements in agriculture and ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

ORNL scientists created a biosensor technology that lets researchers visualize and track RNA activity in living plants, using ...

Scientists at Oak Ridge National Laboratory have developed the first-ever method of detecting ribonucleic acid, or RNA, ...

Spatial transcriptomics technologies opened the door for new kinds of biological measurements, allowing scientists to ...

ORNL scientists created a biosensor technology that lets researchers visualize and track RNA activity in living plants, using ...

Circio and Entos have initiated a research collaboration that will involve joint development and in vivo delivery testing of ...